The effect of klatin capsule on type 2 diabetes

Evaluation of the effect of herbal klatin capsule on laboratory indices and quality of life in type 2 diabetes patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210724051965N1

Enrollment

Registered

2022-01-18

Start date

2022-02-19

Completion date

Unknown

Last updated

2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus. Type 2 diabetes mellitus without complications

Interventions

Intervention 1: Intervention group:In this group patients take their oral diabetes medications without any changes and in addition, they received klatin capsule (Contains 1000 mg of klatin plant extra

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Having type 2 diabetes at least three months before enrollment Adults over 18 years

Exclusion criteria

Exclusion criteria: Pregnancy lactation kidney disease liver disease

Design outcomes

Primary

Measure	Time frame
Fating blood sugar. Timepoint: At the beginning of the study (before the intervention) and 60 days after intervention. Method of measurement: Biochemistry- Glucose oxidase (enzymatic method).;Hemoglobin A1c. Timepoint: At the beginning of the study (before the intervention) and 60 days after intervention. Method of measurement: Biochemistry- Calorimetry.;Cholesterol. Timepoint: At the beginning of the study (before the intervention) and 60 days after intervention. Method of measurement: Calorimetric enzymatic.;Triglyceride. Timepoint: At the beginning of the study (before the intervention) and 60 days after intervention. Method of measurement: Calorimetric enzymatic.	—

Measure

Time frame

Fating blood sugar. Timepoint: At the beginning of the study (before the intervention) and 60 days after intervention. Method of measurement: Biochemistry- Glucose oxidase (enzymatic method).;Hemoglobin A1c. Timepoint: At the beginning of the study (before the intervention) and 60 days after intervention. Method of measurement: Biochemistry- Calorimetry.;Cholesterol. Timepoint: At the beginning of the study (before the intervention) and 60 days after intervention. Method of measurement: Calorimetric enzymatic.;Triglyceride. Timepoint: At the beginning of the study (before the intervention) and 60 days after intervention. Method of measurement: Calorimetric enzymatic.

—

Secondary

Measure	Time frame
Blood creatinine. Timepoint: Before the intervention and 60 days after the intervention. Method of measurement: Enzymatic.;Blood urea nitrogen. Timepoint: Before the intervention and 60 days after the intervention. Method of measurement: Calorimetric enzymatic.;Quality of Life. Timepoint: Before the intervention and 60 days after the intervention. Method of measurement: Quality of Life Assessment Questionnaire 15 questions for patients with diabetes.	—

Measure

Time frame

Blood creatinine. Timepoint: Before the intervention and 60 days after the intervention. Method of measurement: Enzymatic.;Blood urea nitrogen. Timepoint: Before the intervention and 60 days after the intervention. Method of measurement: Calorimetric enzymatic.;Quality of Life. Timepoint: Before the intervention and 60 days after the intervention. Method of measurement: Quality of Life Assessment Questionnaire 15 questions for patients with diabetes.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSedighe Yousefi

Mazandaran University of Medical Sciences

s.yousefi@mazums.ac.ir+98 11 3324 4893

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026